Sintx Technologies (SINT) Income from Continuing Operations (2013 - 2026)
Sintx Technologies (SINT) recorded quarterly Income from Continuing Operations of 2821000.0 in Q1 2026, down 27.36% quarter-over-quarter from 2215000.0 in Q4 2025, and down 23.08% on a YoY basis from 3667460.01 in Q1 2025.
Sintx Technologies (SINT) Income from Continuing Operations (2013 - 2026) Analysis & Trends
Sintx Technologies' Income from Continuing Operations history runs 14 years deep, the most recent figure standing at 2821000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 23.08% year-over-year to 2821000.0; the TTM figure through Mar 2026 stood at 10893000.0 (up 12.37% YoY), while the FY2025 annual figure was 10364000.0, up 5.99% from the prior year.
- Income from Continuing Operations was 2821000.0 for Q1 2026 at Sintx Technologies, down from 2215000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 293000.0 in Q1 2023 to a low of 6239000.0 in Q3 2024.
- Historically, Income from Continuing Operations has averaged 2618058.82 across 5 years, with a median of 2455000.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations soared 89.7% in 2023, then tumbled 202.39% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 3958000.0 in 2022, then soared by 41.36% to 2321000.0 in 2023, then increased by 26.97% to 1695000.0 in 2024, then plunged by 30.68% to 2215000.0 in 2025, then decreased by 27.36% to 2821000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 2821000.0 (Q1 2026), 2215000.0 (Q4 2025), and 3539000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Sintx Technologies | 8.59 Mn | 6.70 Mn | 144,000.00 | -2.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.82 Mn |
| Dec 31, 2025 | -2.22 Mn |
| Sep 30, 2025 | -3.54 Mn |
| Jun 30, 2025 | -2.32 Mn |
| Mar 31, 2025 | -2.29 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Sep 30, 2024 | -6.24 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Mar 31, 2024 | -886,000.00 |
| Dec 31, 2023 | -2.32 Mn |
| Sep 30, 2023 | -3.19 Mn |
| Jun 30, 2023 | -2.46 Mn |
| Mar 31, 2023 | -293,000.00 |
| Dec 31, 2022 | -3.96 Mn |
| Sep 30, 2022 | -2.72 Mn |
| Jun 30, 2022 | -2.51 Mn |
| Mar 31, 2022 | -2.85 Mn |
| Dec 31, 2021 | -2.13 Mn |
| Sep 30, 2021 | -2.34 Mn |
| Jun 30, 2021 | -2.20 Mn |